Two Cases of Eating Disorder Revealed by the Breakout of Acute Kidney Injury After Angiotensin II Receptor Blocker Administration

CEN Case Reports - Japan
doi 10.1007/s13730-012-0055-9
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Suppression of Experimental Autoimmune Uveitis by Angiotensin II Type 1 Receptor Blocker Telmisartan

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2009English

Acute Kidney Injury Secondary to Vitamin D Toxicity: Report of Two Cases

JMS SKIMS
2011English

Summertime Dosage-Dependent Hypersensitivity to an Angiotensin II Receptor Blocker

2014English

Summertime Dosage-Dependent Hypersensitivity to an Angiotensin II Receptor Blocker

2015English

The Angiotensin II Type 1 Receptor Blocker Olmesartan Preferentially Improves Nocturnal Hypertension and Proteinuria in Chronic Kidney Disease

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2012English

Angiotensin Receptor Blocker Protection Against Podocyte-Induced Sclerosis Is Podocyte Angiotensin II Type 1 Receptor-Independent

Hypertension
Internal Medicine
2010English

Recovery After Acute Kidney Injury

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2017English

The Importance of Early Antihypertensive Efficacy: The Role of Angiotensin II Receptor Blocker Therapy

Journal of Human Hypertension
Internal Medicine
2006English

The Significance of Angiotensin Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Use in Sudden Cardiac Death

International Journal of Clinical Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy